Symbol Name ID |
Nfkb2
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 MGI:1099800 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Decreased circulating IgA level |
Decreased circulating IgG level |
Decreased circulating total IgM |
Disease(s) Associated with NFKB2 | |||
common variable immunodeficiency 10 |
Mouse Phenotypes | hematopoietic system phenotype |
increased splenocyte apoptosis |
abnormal osteoclast differentiation |
decreased B cell proliferation |
increased B cell proliferation |
increased T cell proliferation |
abnormal thymus cell ratio |
abnormal thymus corticomedullary boundary morphology |
abnormal thymus size |
thymus atrophy |
abnormal thymus physiology |
enlarged spleen |
increased spleen weight |
abnormal definitive hematopoiesis |
abnormal B cell differentiation |
abnormal class switch recombination |
decreased transitional stage B cell number |
decreased transitional stage T2 B cell number |
increased transitional stage B cell number |
abnormal plasma cell differentiation |
abnormal T cell differentiation |
abnormal CD4-positive T cell differentiation |
abnormal CD8-positive, alpha-beta T cell differentiation |
increased double-negative T cell number |
decreased double-positive T cell number |
increased double-positive T cell number |
extramedullary hematopoiesis |
anemia |
increased granulocyte number |
decreased myeloid dendritic cell number |
increased plasmacytoid dendritic cell number |
decreased dendritic cell number |
abnormal lymphocyte cell number |
decreased mature B cell number |
decreased B-2 B cell number |
decreased follicular B cell number |
decreased marginal zone B cell number |
increased B-1 B cell number |
increased B-1a cell number |
decreased B cell number |
decreased NK cell number |
abnormal T cell subpopulation ratio |
abnormal T cell number |
decreased CD4-positive, alpha-beta T cell number |
increased CD4-positive, alpha-beta T cell number |
decreased effector memory CD8-positive, alpha-beta T cell number |
increased CD8-positive, naive alpha-beta T cell number |
increased CD8-positive, alpha-beta T cell number |
decreased gamma-delta T cell number |
increased T cell number |
increased lymphocyte cell number |
abnormal myeloid dendritic cell morphology |
abnormal gamma-delta T cell morphology |
abnormal metallophilic macrophage morphology |
abnormal spleen marginal zone macrophage morphology |
abnormal spleen morphology |
increased spleen red pulp amount |
intermingled spleen red and white pulp |
decreased spleen weight |
spleen atrophy |
spleen hypoplasia |
abnormal spleen white pulp morphology |
abnormal spleen B cell follicle morphology |
abnormal spleen follicular dendritic cell network |
abnormal spleen primary B follicle morphology |
abnormal spleen secondary B follicle morphology |
absent spleen germinal center |
abnormal spleen marginal zone morphology |
absent spleen marginal zone |
abnormal spleen periarteriolar lymphoid sheath morphology |
abnormal immunoglobulin level |
decreased IgA level |
decreased IgG1 level |
decreased IgG2a level |
increased IgG2a level |
decreased IgG2b level |
decreased IgG3 level |
decreased IgM level |
increased IgM level |
decreased immunoglobulin level |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2Lym1/Nfkb2Lym1 | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2m2Btlr/Nfkb2m2Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2m3Btlr/Nfkb2m3Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2M4Btlr/Nfkb2M4Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2m5Btlr/Nfkb2m5Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2tm1Brv/Nfkb2tm1Brv | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2tm1Rsch/Nfkb2tm1Rsch | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2tm1Sbn/Nfkb2tm1Sbn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2tm2Brv/Nfkb2tm2Brv | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2xdr/Nfkb2xdr | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nfkb2Lym1/Nfkb2+ |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|